Education

Peptides: facts, not hype

On Instagram and TikTok, "research peptides" are sold as miracle cures for fat loss, muscle growth and recovery. Here are the facts about the best-known products: approval status, evidence and risks – explained briefly, with sources.

None of the products described here is approved as a drug in the US, the EU or Austria. This page is for education only. We do not recommend any of these substances, do not sell them, and give no doses and no sources. If you are thinking about medication for weight loss, recovery or hormone deficiency, talk to your doctor.

What are peptides anyway?

Peptides are short chains of amino acids – the building blocks of protein. Many hormones in the body are peptides. There are more than a hundred approved peptide-based drugs, for example insulin or GLP-1 drugs for diabetes and obesity. [1]

These must be distinguished from so-called research peptides: substances that have never gone through an approval process and are sold online labeled "for research use only" or "not for human consumption". This label is a way for gray-market sellers to get around drug laws. [1]

The best-known peptides at a glance

Weight loss

Retatrutide ("reta")

Not approvedPhase 3 trialsWADA S0

A drug candidate from Eli Lilly that acts on three hormone receptors at once (GIP, GLP-1, glucagon). In large trials under medical supervision, up to about 28–30% weight loss. [2] US approval application planned for early 2027 at the earliest. [3]

  • Common: nausea, vomiting, diarrhea, constipation; also abnormal skin sensations [2]
  • Black-market product: six cases of acute liver injury reported in Australia [4]

All the facts about retatrutide →

"Recovery"

BPC-157

Not approvedHardly any human dataWADA S0

A peptide derived from gastric juice, promoted for tendon, joint and gut healing. Almost all data come from animal studies. In humans there are only three small studies with fewer than 30 people combined – none of them randomized and controlled. [5] A systematic review found no study examining safety in humans. [6]

  • Safety in humans unknown [6]
  • Theoretical risk: promoting new blood vessel growth, which can also favor tumor growth [7]
  • The FDA cites possible immune reactions and impurities [8]

In July 2026 an FDA advisory committee narrowly recommended (8:6) allowing BPC-157 for pharmacy compounding – against the recommendation of FDA staff. That is not drug approval and is not binding for the FDA. [9][10]

"Recovery"

TB-500

Not approvedHardly any human dataWADA S2

A synthetic fragment of the body's own thymosin β4, promoted for healing and recovery. The existing human studies concern natural thymosin β4 – for example as eye drops or an infusion in small trials – not the TB-500 fragment that is sold. [11][12]

  • Efficacy and safety of the fragment in humans not established
  • Thymosin-β4 derivatives such as TB-500 are explicitly on the doping list [13]
  • Gray market: purity and content untested [1]
Growth hormone

CJC-1295 & ipamorelin

Not approvedPhase 1 data onlyWADA S2

Stimulate the body's own release of growth hormone, promoted for fat loss, muscle growth and sleep. For CJC-1295 there are only small studies on hormone levels in healthy people; for the most commonly sold version without "DAC" there are no published human studies. Ipamorelin missed its primary endpoint in a controlled trial after bowel surgery. [14][15]

  • Possible consequences: impaired blood sugar regulation, water retention, edema [16]
  • Theoretically: promoting growth of undetected tumors [16]
  • The FDA lists CJC-1295 as a substance with safety concerns due to reports of vascular reactions and racing heart [14]
  • No evidence that growth hormone stimulation as "anti-aging" extends life [16]
Others

MOTS-c, epitalon, semax, KPV, GHK-Cu

Not approvedVery little human dataWADA S0

Promoted for metabolism, "anti-aging", focus or skin. FDA experts found limited characterization, insufficient safety data and hardly any evidence of efficacy for these substances. [17] The advisory committee nevertheless narrowly recommended allowing some of them for pharmacy compounding in the US – that is not drug approval. [10]

More products at a glance

Besides the best-known peptides, many other substances are circulating. Some of them are actually approved for narrowly defined uses – but that doesn't mean "research" products with the same name are tested or safe.

ProductStatusWhat is known
Semaglutide (Ozempic, Wegovy) & tirzepatide (Mounjaro, Zepbound)Approved – prescription onlyEffective, tested drugs. The danger is counterfeits: the WHO issued a global warning about falsified semaglutide pens [20]; some contained insulin instead of semaglutide and caused severe low blood sugar and seizures. [21] In Austria, too, people had to be hospitalized after counterfeit products. [22]
Melanotan II ("Barbie drug")Not approvedTanning peptide. Darkening and new moles have been described, as well as at least five melanoma cases during or after use – a causal link has not been proven. [23] There are also case reports of kidney infarction, muscle breakdown (rhabdomyolysis) and painful prolonged erections. [24]
MK-677 (ibutamoren)Not approvedA pill that releases growth hormone. Raised blood sugar in studies; a study in older patients was stopped early due to a feared increase in heart failure. [25]
AOD-9604Not approvedA growth hormone fragment marketed as a "fat burner". Development as a weight-loss drug was stopped in 2007 because it produced no meaningful weight loss in a study with 536 participants. [26]
Tesamorelin (Egrifta)Approved in the US for one indication onlyApproved only for reducing abdominal fat in people with HIV-associated lipodystrophy. Raises IGF-1; according to the prescribing information, levels should be monitored closely, and it must not be used with active cancer. [27] Prohibited for athletes (WADA S2).
PT-141 (bremelanotide)Approved in the US for one indicationApproved as Vyleesi only for low sexual desire in premenopausal women. Product sold online as "PT-141" is not a tested drug. [28]
GHK-CuCosmetics yes, injection not approvedA copper peptide studied in skincare. Injecting it as "anti-aging" has no tested approval. [29]
EpitalonNot approvedPromoted as telomere "rejuvenation". In humans only small biomarker studies; no sufficiently large study has shown efficacy. Safety and long-term data insufficient. [30]
MOTS-cNot approvedA natural peptide from the mitochondria; effects mainly in animal studies. No effective clinical use has been developed. [31]
Semax, selank, KPV, LL-37, thymosin alpha-1Not approved in the US/EUPromoted for focus, anxiety, inflammation or the immune system. There are no solid studies for use as lifestyle products; reviews classify them as substances with uncertain safety and limited evidence. [32]

Had an experience? Tell us.

Have you used one of these products and noticed side effects – or simply want to share how it went? Share your experience, anonymously if you like. We don't ask for doses or sources and never publish names.

Report my experience

The risks all research peptides share

  • Unknown content: amount, purity and identity are untested. Vials may contain contaminants, wrong amounts or entirely different substances. [1]
  • Organ damage: the Australian drug regulator TGA reports serious adverse effects after illegal peptides, including liver damage, severe allergic reactions and inflammation. [18]
  • Immune reactions: injected peptides can trigger allergic reactions up to anaphylactic shock, or autoimmune reactions. [1]
  • Infections: powders reconstituted and injected at home without tested sterility can lead to inflammation and abscesses at the injection site.
  • No long-term data: for none of these products is it known what use over months or years does.
  • Doping: for drug-tested athletes, all substances mentioned here are prohibited at all times. [13][19]
  • Legal situation: unapproved drugs may not be marketed for human use in the US or the EU. If you order such products, you have no quality or liability protection whatsoever.

Frequently asked questions

Are research peptides approved in the US or the EU?

No. Retatrutide, BPC-157, TB-500, CJC-1295, ipamorelin, MOTS-c and similar products are not approved as drugs by the FDA or in the EU. Unapproved drugs may not legally be marketed for human use.

What does "for research use only" mean?

The label "for research use only" or "not for human consumption" means the product is not intended for use in humans and has not been tested. Sellers use it to get around drug laws – it does not make the product any safer.

Are peptides allowed for athletes?

For athletes subject to drug testing, unapproved substances (WADA category S0), growth hormone-releasing peptides and thymosin-β4 derivatives (category S2) are prohibited at all times.

Are there approved peptide drugs?

Yes. There are more than a hundred approved peptide-based drugs, for example insulin or GLP-1 drugs such as semaglutide. They are tested for quality, efficacy and safety and are prescribed by a doctor.

A fact sheet on every peptide in the Premium plan

Premium members get a separate PDF fact sheet for every product – retatrutide, BPC-157, TB-500, CJC-1295, ipamorelin, MK-677, melanotan II, AOD-9604, tesamorelin, PT-141, GHK-Cu, epitalon, MOTS-c and counterfeit semaglutide/tirzepatide: evidence, all known risks, approval status, doping, warning signs, questions for your doctor and sources. Education only, no instructions.

See Premium

Sources

  1. National Consumers League: “Warning About Self-Injecting ‚Research-Grade' Synthetic Peptides”. nclnet.org
  2. The Pharmaceutical Journal: “Phase III retatrutide study demonstrates 30% weight loss”, May 2026. pharmaceutical-journal.com
  3. Eli Lilly and Company: press release TRIUMPH-2/-3, July 23, 2026. investor.lilly.com
  4. Department of Health Victoria: Health Alert “Toxicity linked to unapproved peptide product labelled Retatrutide”, June 19, 2026. health.vic.gov.au
  5. “BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers”, 2026. PubMed Central. pmc.ncbi.nlm.nih.gov
  6. “Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review”. PubMed Central. pmc.ncbi.nlm.nih.gov
  7. “Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing”. PubMed Central. pmc.ncbi.nlm.nih.gov
  8. U.S. Food and Drug Administration: “Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks”. fda.gov
  9. RAPS Regulatory Focus: “FDA advisory committee backs two controversial peptides”, July 23, 2026. raps.org
  10. Mintz: “FDA's Advisory Committee Votes on Peptides: What It Does and Doesn't Do”, July 29, 2026. mintz.com
  11. “A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers”. PubMed Central. pmc.ncbi.nlm.nih.gov
  12. “Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial”. PubMed Central. pmc.ncbi.nlm.nih.gov
  13. “Annual Banned-Substance Review 18th Edition – Analytical Approaches in Human Sports Drug Testing 2024/2025” (overview of WADA classes S0/S2). PubMed Central. pmc.ncbi.nlm.nih.gov
  14. “The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration”, 2026. PubMed Central. pmc.ncbi.nlm.nih.gov
  15. “Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males”. PubMed Central. pmc.ncbi.nlm.nih.gov
  16. “Dangers of Injectable Peptides and Other Unregulated ‚Biohacking' Drugs”. PubMed Central. pmc.ncbi.nlm.nih.gov
  17. Buchanan Ingersoll & Rooney: “FDA PCAC Recommends Six Peptides for the 503A Bulks List”, 2026. bipc.com
  18. newsGP (RACGP): “Illegal peptide warnings intensify amid acute liver toxicity”, June 22, 2026. racgp.org.au
  19. World Anti-Doping Agency (WADA): Prohibited List 2026. wada-ama.org
  20. Euronews: “Ozempic: Global health authorities issue warning about falsified injection pens” (WHO warning), June 21, 2024. euronews.com
  21. NBC News: “Health authorities around the globe issue warnings about fake Ozempic”. nbcnews.com
  22. NBC News (see [21]): report on hospitalizations in Austria after counterfeit products, according to Austrian authorities.
  23. “An overview of benefits and risks of chronic melanocortin-1 receptor activation”. PubMed Central. pmc.ncbi.nlm.nih.gov
  24. “Insights into Tanning Biology and Tanning Products”. PubMed Central. pmc.ncbi.nlm.nih.gov
  25. Sigalos JT, Pastuszak AW: “The Safety and Efficacy of Growth Hormone Secretagogues”. PubMed Central. pmc.ncbi.nlm.nih.gov
  26. “Central and Peripheral Molecular Targets for Anti-Obesity Pharmacotherapy”. PubMed Central. pmc.ncbi.nlm.nih.gov
  27. Drugs.com: “FDA Approves Egrifta (tesamorelin for injection)” incl. Sicherheitshinweisen. drugs.com
  28. Overview of FDA-approved peptides (bremelanotide/Vyleesi). peptidehelp-usa
  29. “The potential of GHK as an anti-aging peptide”. PubMed Central. pmc.ncbi.nlm.nih.gov
  30. “Epitalon and Epithalamin: A Narrative Review of Mechanistic, Preclinical, and Clinical Evidence”, 2026. PubMed Central. pmc.ncbi.nlm.nih.gov
  31. “MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation”. PubMed Central. pmc.ncbi.nlm.nih.gov
  32. Hailu KT et al.: “Unregulated Peptide Use in the Age of Biohacking”. Cureus 2026. PubMed Central. pmc.ncbi.nlm.nih.gov

Information as of November 2026. Approval status and evidence change constantly. This page does not replace medical advice. Information only – not a recommendation, not advice on use or treatment and not medical advice. Content is reproduced in summary from the sources cited. We accept no liability for the accuracy, completeness or timeliness of the content or for decisions made on the basis of it; the original source is authoritative.